pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
Vijoice
Vijoice (alpelisib)
$NVS
NOVARTIS AG
0
catalysts
Preclinical
Viral Diseases
Coronavirus Disease 2019 (COVID-19)
Max Biopharma Inc
0
catalysts
Marketed
Vistogard
Vistogard (uridine triacetate)
Chemotherapy Effects
BTG International Inc
0
catalysts
Marketed
Vogelxo
← prev
page 175 of 271
next →
131
Pain
89
Neurology
1
Testosterone Upsher-Smith (testosterone)
Secondary (Hypogonadotropic) Hypogonadism
Upsher-Smith Laboratories LLC
0
catalysts
Marketed
Vostally
Vostally (ramipril)
Cardiovascular Risk Factors
Rosemont Pharmaceuticals Ltd
0
catalysts
Marketed
Vyvanse
Vyvanse (lisdexamfetamine)
ADHD, binge eating disorder
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Phase 2
Vyznova
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
0
catalysts
WAINUA (AUTOINJECTOR)
WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM)
amyloidosis
Transthyretin mRNA
$AZN
ASTRAZENECA PLC
0
catalysts
WAKIX
WAKIX (PITOLISANT HYDROCHLORIDE)
1 INDICATIONS AND USAGE WAKIX is indicated for the treatment of excessive day…
Histamine H3 receptor
$HRMY
Harmony Biosciences Holdings, Inc.
0
catalysts
Phase 1
WCK-6777
Pyelonephritis
Wockhardt Ltd
0
catalysts
Preclinical
WD-1804
(carbidopa + levodopa)
Parkinson's Disease
Hong Kong WD Pharmaceutical Co Ltd
0
catalysts
WELLBUTRIN
WELLBUTRIN (BUPROPION HYDROCHLORIDE)
GlaxoSmithKline LLC
0
catalysts
WELLBUTRIN SR
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)
GlaxoSmithKline LLC
0
catalysts
WELLCOVORIN
WELLCOVORIN (LEUCOVORIN CALCIUM)
GlaxoSmithKline LLC
0
catalysts
WINREVAIR
WINREVAIR (SOTATERCEPT-CSRK)
Merck Sharp & Dohme LLC
0
catalysts
Preclinical
WOREE/SCAR12 (WWOX Deficiency)
Epileptic Encephalopathy
Mahzi Therapeutics Inc
0
catalysts
Phase 2
WP-1066
Glioblastoma Multiforme (GBM)
$MBRX
Moleculin Biotech, Inc.
0
catalysts
Preclinical
WP-1096
Coronavirus Disease 2019 (COVID-19)
$MBRX
Moleculin Biotech, Inc.
0
catalysts
Preclinical
WP-1097
Coronavirus Disease 2019 (COVID-19)
$MBRX
Moleculin Biotech, Inc.
0
catalysts
Preclinical
WSD-0329
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0
catalysts
Phase 1
WSD-0628
Astrocytoma
Wayshine Biopharma Inc
0
catalysts
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
0
catalysts
Preclinical
WSD-1227
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0
catalysts
Phase 2
WTX-330
Colorectal Cancer
$HOWL
Werewolf Therapeutics, Inc.
0
catalysts
Phase 2
WVE-007
Obesity
$WVE
Wave Life Sciences Ltd.
0
catalysts
Phase 2
WVEN-531
Duchenne Muscular Dystrophy
$WVE
Wave Life Sciences Ltd.
0
catalysts
pre_registration
Wegovy
Wegovy (semaglutide)
Diastolic Heart Failure (HFpEF)
Glucagon-like peptide 1 receptor
Novo Nordisk AS
0
catalysts
Phase 2
Wiskott-Aldrich Syndrome
Wiskott-Aldrich Syndrome
Thrombopoietin receptor
Genethon SA
0
catalysts
Marketed
Wynzora
Wynzora ((betamethasone dipropionate + calcipotriene))
Plaque Psoriasis (Psoriasis Vulgaris)
MC2 Therapeutics AS
0
catalysts
Preclinical
X-004
Hemorrhagic Cystitis (Haemorrhagic Cystitis)
Ixaltis
0
catalysts
